#BEGIN_DRUGCARD DB02959

# AHFS_Codes:
Not Available

# ATC_Codes:
N06AX01

# Absorption:
Not Available

# Biotransformation:
5-Hydroxytryptophan is decarboxylated to serotonin (5-hydroxytryptamine or 5-HT) by the enzyme aromatic-L-amino-acid decarboxylase with the help of vitamin B6. This reaction occurs both in nervous tissue and in the liver.

# Brand_Mixtures:
Not Available

# Brand_Names:
Levothym

# CAS_Registry_Number:
4350-09-8

# ChEBI_ID:
17780

# Chemical_Formula:
C11H12N2O3

# Chemical_IUPAC_Name:
(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
5-Hydroxytryptophan (5-HTP), also known as oxitriptan (INN), is a naturally occurring amino acid and chemical precursor as well as a metabolic intermediate in the biosynthesis of the neurotransmitters serotonin and melatonin from tryptophan. 5-HTP is sold over-the-counter in the United Kingdom, United States and Canada as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, and is also marketed in many European countries for the indication of major depression under trade names like Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum. Several double-blind placebo-controlled clinical trials have demonstrated the effectiveness of 5-HTP in the treatment of depression, though a lack of high quality studies has been noted. More and larger studies are needed to determine if 5-HTP is truly effective in treating depression.

# Dosage_Forms:
Capsule	Oral
Capsule	Oral

# Drug_Category:
Antidepressive Agents, Second-Generation

# Drug_Interactions:
Not Available

# Drug_Reference:
1088369	Amamoto T, Sarai K: On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression. Hiroshima J Med Sci. 1976 Sep;25(2-3):135-40.
11869656	Shaw K, Turner J, Del Mar C: Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002;(1):CD003198.
15893130	Turner EH, Blackwell AD: 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Med Hypotheses. 2005;65(1):138-44.
18445233	Nakatani Y, Sato-Suzuki I, Tsujino N, Nakasato A, Seki Y, Fumoto M, Arita H: Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. Eur J Neurosci. 2008 May;27(9):2466-72.
2193835	Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 1990 May-Jun;18(3):201-9.
3913752	De Benedittis G, Massei R: Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo. J Neurosurg Sci. 1985 Jul-Sep;29(3):239-48.
39668	Bouchard S, Roberge AG: Biochemical properties and kinetic parameters of dihydroxyphenylalanine--5-hydroxytryptophan decarboxylase in brain, liver, and adrenals of cat. Can J Biochem. 1979 Jul;57(7):1014-8.
6175178	Magnussen I, Jensen TS, Rand JH, Van Woert MH: Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man. Acta Pharmacol Toxicol (Copenh). 1981 Sep;49(3):184-9.
6983619	Rahman MK, Nagatsu T, Sakurai T, Hori S, Abe M, Matsuda M: Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. Jpn J Pharmacol. 1982 Oct;32(5):803-11.
6997735	Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CK: Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med. 1980 Oct 2;303(14):782-7.
7733839	Trouillas P, Serratrice G, Laplane D, Rascol A, Augustin P, Barroche G, Clanet M, Degos CF, Desnuelle C, Dumas R, et al.: Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study. Arch Neurol. 1995 May;52(5):456-60.
9727088	Birdsall TC: 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271-80.
9727088	Birdsall TC: 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271-80.

# Drug_Type:
Approved
Nutraceutical
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Oxitriptan

# HET_ID:
HRP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1

# InChI_Key:
InChIKey=LDCYZAJDBXYCGN-VIFPVBQESA-N

# Indication:
For use as an antidepressant, appetite suppressant, and sleep aid.

# KEGG_Compound_ID:
C00643

# KEGG_Drug_ID:
D07339

# LIMS_Drug_ID:
2959

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
220.2246

# Molecular_Weight_Mono:
220.08479226

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
1YIA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
The psychoactive action of 5-HTP is derived from its effect on the production of serotonin in central nervous system tissue. More specifically, 5-HTP increases the production of serotonin.

# Predicted_LogP_Hydrophobicity:
-1.6

# Predicted_LogS:
-1.8

# Predicted_Water_Solubility:
3.63e+00 g/l

# Primary_Accession_No:
DB02959

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01780

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
5-Hydroxy-L-Tryptophan
Hydroxy-5 L-tryptophane

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:42 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/5-Hydroxytryptophan

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000513

# Drug_Target_1_GenBank_ID_Protein:
6458825

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
trpS2

# Drug_Target_1_Gene_Sequence:
>1056 bp
TTGCCTTTCGTTGATCTGGAGGTTCCGACCATGACCACCCCGACCCCTGCCGCTACACCT
GCCCGCCCCCGCGTCCTGACCGGGGACCGGCCCACCGGGGCGCTGCACCTCGGGCACCTC
GCCGGGTCGCTGCAAAACCGGGTGCGCTTGCAAGACGAGGCCGAGCTGTTCGTGCTGCTT
GCCGACGTGCAGGCGCTCACCGACCACTTCGACCGGCCCGAGCAGGTGCGCGAGAACGTG
CTGGCGGTGGCGCTCGATTACCTCGCCGCCGGGCTCGACCCGCAGAAGACGACCTGCGTG
GTGCAGTCGGCGGTGCCCGAACTCGCCGAGCTGACGGTCTATTTCCTCAATCTGGTCACG
GTGTCGCACCTGCGCCAGAACCCCACCGTCAAGGCCGAAATCGCGCAAAAGGGCTACGGC
GAGCGGGTTCCTGCCGGGTTTTTCGTGTATCCGGTGTCGCAGGCCGCCGACATCGCCGCG
TTCGGGGCCACGCTGGTGCCGGTGGGCGACGACCAGTTGCCGATGCTCGAACAGACCCGC
GAAATCGTGCGGCGCTTCAATGCGCTGTATGCCCCGGTGCTCGCCGAGCCGCAGGCGCAG
CTCAGCCGGGTGCCGCGTCTGCCGGGGCTCGACGGGCAGGCCAAGATGAGCAAGTCGCTC
GGCAACGCGATTGCGCTCGGCGACTCTGCCGACGAGGTGGCGCGCAAGGTCATGGGCATG
TACACCGACCCTGGCCACCTGCGGGCAAGTGATCCCGGACGGGTGGAGGGCAATCCGGTC
TTCACCTTCCTCGACGCCTTCGACCCCGATCCGGCGCGGGTGCAGGCGTTGAAAGACCAG
TACCGCGCGGGCGGCCTCGGTGACGTGAAGGTCAAAAAGCACCTGATTGACGTGCTCAAC
GGGGTGCTGGCTCCCATCCGCACGCGGCGCGCCGAGTATGAGCGCGACCCCGACGCCGTG
CTCCGGTTCGTCACGGAGGGCACGGCGCGGGGCCGGGAGGTGGCGGCGCAGACGCTCGGG
CAGGTGCGGCGGGCGATGCGGTTGTTTGGGCACTGA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
10567266	White O, Eisen JA, Heidelberg JF, Hickey EK, Peterson JD, Dodson RJ, Haft DH, Gwinn ML, Nelson WC, Richardson DL, Moffat KS, Qin H, Jiang L, Pamphile W, Crosby M, Shen M, Vamathevan JJ, Lam P, McDonald L, Utterback T, Zalewski C, Makarova KS, Aravind L, Daly MJ, Minton KW, Fleischmann RD, Ketchum KA, Nelson KE, Salzberg S, Smith HO, Venter JC, Fraser CM: Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science. 1999 Nov 19;286(5444):1571-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3329

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38180

# Drug_Target_1_Name:
Tryptophanyl-tRNA synthetase 2

# Drug_Target_1_Number_of_Residues:
351

# Drug_Target_1_PDB_ID:
1YIA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00579	tRNA-synt_1b

# Drug_Target_1_Protein_Sequence:
>Tryptophanyl-tRNA synthetase 2
MPFVDLEVPTMTTPTPAATPARPRVLTGDRPTGALHLGHLAGSLQNRVRLQDEAELFVLL
ADVQALTDHFDRPEQVRENVLAVALDYLAAGLDPQKTTCVVQSAVPELAELTVYFLNLVT
VSHLRQNPTVKAEIAQKGYGERVPAGFFVYPVSQAADIAAFGATLVPVGDDQLPMLEQTR
EIVRRFNALYAPVLAEPQAQLSRVPRLPGLDGQAKMSKSLGNAIALGDSADEVARKVMGM
YTDPGHLRASDPGRVEGNPVFTFLDAFDPDPARVQALKDQYRAGGLGDVKVKKHLIDVLN
GVLAPIRTRRAEYERDPDAVLRFVTEGTARGREVAAQTLGQVRRAMRLFGH

# Drug_Target_1_Reaction:
ATP + L-tryptophan + tRNATrp = AMP + diphosphate + L-tryptophyl-tRNATrp

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the formation of 5'adenyl-Trp and tRNA(Trp) but with 5-fold less activity than trpRS. Increases the solubility of the nitric oxide synthase oxygenase (nos), as well as its affinity for substrate L-arginine and its nitric-oxide synthase activity. The complex between trpS2 and nos catalyzes the regioselective nitration of tryptophan at the 4-position

# Drug_Target_1_SwissProt_ID:
Q9RVD6

# Drug_Target_1_SwissProt_Name:
SYW2_DEIRA

# Drug_Target_1_Synonyms:
EC 6.1.1.2
TrpRS II
Tryptophan--tRNA ligase II
Tryptophanyl-tRNA synthetase II

# Drug_Target_1_Theoretical_pI:
6.64

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02959
